NDA 208536 describes BUSULFAN, which is a drug marketed by
Accord Hlthcare Inc,
Actavis,
Am Regent,
Amneal,
Apotex,
Arthur Grp,
Hospira,
Meitheal,
Mylan Institutional,
Mylan Labs Ltd,
Nexus,
Pharmascience Inc, and
Shilpa, and is included in thirteen NDAs. It is available from
ten suppliers. Additional details are available on the
BUSULFAN profile page.
The generic ingredient in BUSULFAN is
busulfan. There are ten
drug master file entries for this compound. Thirteen
suppliers are listed for this compound. Additional details are available on the
busulfan profile page.